Lantheus Holdings Inc Asset Turnover Ratio (LNTH), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lantheus Holdings Inc   (NASDAQ: LNTH)
 

Lantheus Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the first quarter 2026, Lantheus Holdings Inc 's asset turnover ratio sequentially decreased to 0.7 in the first quarter (Mar 31 2026), this is lower than usual.

Within sector 10 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2537, from total ranking in the fourth quarter 2025 at 2662.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LNTH Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 9.7 % 22.95 % 19.4 % 18.31 % 21.32 %
Y / Y Revenue Change 1.13 % 3.92 % 1.39 % -4 % 0.77 %
Asset Turnover Ratio (TTM) 0.7 0.71 0.74 0.77 0.81
LNTH's Total Ranking # 2537 # 2662 # 1366 # 2494 # 2521
Seq. Asset Change 1.22 % -2.15 % 7.58 % 2.96 % 13.45 %
Seq. Revenue Change -7.36 % 6.13 % 1.42 % 1.43 % -4.81 %



Asset Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 11
Healthcare Sector # 393
Overall Market # 2537

Asset Turnover Ratio Statistics
High Average Low
8.21 6.25 4.26
(Jun 30 2017)   (Mar 31 2026)




LNTH Company Profile • Back to LNTH Efficiency Comparisons • Compare LNTH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Biocryst Pharmaceuticals Inc   1.88 $ 885.716  Millions$ 470.706  Millions
Integrated Biopharma Inc  1.88 $ 47.241  Millions$ 25.164  Millions
Nature s Sunshine Products inc   1.88 $ 489.104  Millions$ 260.571  Millions
Arbutus Biopharma Corp  1.85 $ 191.445  Millions$ 103.406  Millions
Innovage Holding Corp   1.80 $ 949.172  Millions$ 527.990  Millions
Talkspace Inc   1.80 $ 239.269  Millions$ 133.225  Millions
International Stem Cell Corporation  1.79 $ 9.286  Millions$ 5.195  Millions
Iridex Corp  1.74 $ 51.160  Millions$ 29.341  Millions
Progyny Inc   1.73 $ 1,292.760  Millions$ 749.237  Millions
Cv Sciences Inc   1.67 $ 11.925  Millions$ 7.157  Millions
Privia Health Group Inc   1.66 $ 2,246.592  Millions$ 1,352.700  Millions
Option Care Health Inc   1.65 $ 5,666.577  Millions$ 3,424.635  Millions
Chemed Corporation  1.58 $ 2,540.548  Millions$ 1,603.867  Millions
Koru Medical Systems Inc   1.58 $ 43.257  Millions$ 27.353  Millions
Adm Tronics Unlimited Inc   1.57 $ 3.347  Millions$ 2.126  Millions
Interpace Biosciences Inc   1.56 $ 35.664  Millions$ 22.905  Millions
Kewaunee Scientific Corporation  1.52 $ 280.595  Millions$ 184.208  Millions
Marpai Inc  1.50 $ 17.125  Millions$ 11.408  Millions
Viemed Healthcare Inc   1.49 $ 291.617  Millions$ 195.870  Millions
Qhslab Inc   1.48 $ 2.775  Millions$ 1.876  Millions
Nephros Inc   1.47 $ 19.464  Millions$ 13.231  Millions
Evofem Biosciences Inc   1.45 $ 20.237  Millions$ 13.976  Millions
Rosecliff Acquisition Corp I  1.45 $ 23.433  Millions$ 16.202  Millions
Medpace Holdings Inc   1.44 $ 2,678.268  Millions$ 1,857.442  Millions
Infusystem Holdings Inc  1.43 $ 142.404  Millions$ 99.737  Millions
Medinotec Inc   1.42 $ 9.729  Millions$ 6.849  Millions
Vaxart Inc   1.38 $ 255.609  Millions$ 184.802  Millions
Karyopharm Therapeutics Inc   1.37 $ 151.118  Millions$ 110.236  Millions
Sanara Medtech Inc   1.37 $ 106.873  Millions$ 78.019  Millions
Evolus Inc   1.35 $ 302.349  Millions$ 223.579  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.